2018年8月6日

美國東部時間2018年8月5日22:34 | bioortfolio報告摘要SomaGenics Inc SomaGenics是一家開發和商業化治療藥物的生物技術公司。該公司提供小RNA技術，包括使用sshRNA分子的基於rnai的治療，以及小或片段RNA(包括microRNAs)的診斷或生物標誌物檢測。它為下一代測序和定量實時RTPCR分析miRNA提供了小RNA文庫製備。SomaGenics提供RNA檢測程序，開發了下一代測序試劑盒和qPCR技術。它還提供從總RNA或生物流體樣本中提取的mirna和其他小RNA的測序服務。該公司的產品用於丁型肝炎病毒治療和傷口愈合應用。它與學術機構、大學、醫學院、醫療中心和大學合作。SomaGenics總部位於美國加利福尼亞州聖克魯斯。該報告是關於公司管道產品組合的數據、分析和可操作情報的來源。該報告提供了有關該公司、其主要產品和品牌的關鍵信息。 The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments The report analyzes all pipeline products in development for the company SomaGenics Inc The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date The report provides detailed description of products in development, technical specification and functions The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio To formulate effective Research Development strategies Develop marketentry and market expansion strategies Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio Note: Some sections may be missing if data is unavailable for the company Related Biotechnology, Pharmaceutical and Healthcare News